Stocktoria

Eloxx Pharmaceuticals, Inc. ELOX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-11-23 · LEI

Eloxx Pharmaceuticals, Inc. statistics & valuation

Market cap$505,139
Net cash$3.8M
Enterprise value USD-$3.3M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201720182019202020212022202320242025
Operating margin (%)
-38.80% 2017201720182019202020212022202320242025
Return on equity (%)
-107.20% -99.30% -110.00% -140.50% -338.00% -298.10% 2017201720182019202020212022202320242025
Shares outstanding
29.2M 27.5M 35.9M 40.0M 40.2M 2.2M 2.2M 3.1M 3.8M 12.3M 2017201720182019202020212022202320242025
Net debt ($)
-$8.6M -$14.0M -$30.3M -$7.5M $478000 -$111000 -$3.8M 2017201720182019202020212022202320242025
Share buybacks ($)
2017201720182019202020212022202320242025
Return on assets (%)
-16.00% -85.60% -93.00% -86.30% -130.60% -147.80% -170.70% -996.10% -105.60% -113.80% 2017201720182019202020212022202320242025
Free cash flow margin (%)
2017201720182019202020212022202320242025
Debt / equity (×)
0.38× 1.05× 0.54× 2017201720182019202020212022202320242025
EPS ($)
-$38.15 -$16.65 -$6.63 -$0.84 -$0.49 2017201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Operating margin—-38.8%————————
Net margin—-49.4%————————
Return on assets-113.8%-105.6%-996.1%-170.7%-147.8%-130.6%-86.3%-93.0%-85.6%-16.0%
Return on equity50.3%12.9%75.5%338.3%-298.1%-338.0%-140.5%-110.0%-99.3%-107.2%
Debt / equity-0.08×-0.00×-0.07×-1.10×0.54×1.05×0.38×———
Current ratio0.310.110.070.874.372.634.896.457.160.10

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.